Envoy Medical, Inc.
Envoy Medical, Inc.
- Market cap
- $540.80K
Your view on COCHW
Overview
What the company does, where it operates, and who runs it.
About Envoy Medical, Inc.
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Brent T. Lucas
- Headquarters
- 4875 White Bear Parkway, White Bear Lake, MN, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Brent T. Lucas
- Headquarters
- 4875 White Bear Parkway, White Bear Lake, MN, US
Specializing in auditory health, Envoy Medical, Inc. crafts medical technologies designed to address the full spectrum of hearing impairment.
Its comprehensive suite of products features personal sound amplifiers, conventional hearing aids, the Esteem fully implanted active middle ear device, auditory osseointegrated implants, and Acclaim cochlear implants.
Established in 1995, this White Bear Lake, Minnesota-based company rebranded from Envoy Medical Corporation to Envoy Medical, Inc. in September 2023.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Envoy Medical, Inc.. Starting points for Envoy Medical, Inc.: EPS -$2.00, beta 1.89 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Envoy Medical, Inc.. Trailing twelve-month EPS for Envoy Medical, Inc. stands at -$2.00. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | −$0.65 | −$0.61 | −$2.62 | −$2.44 |
| Lowest estimate | −$0.72 | −$0.67 | −$3.89 | −$3.61 |
| Highest estimate | −$0.52 | −$0.48 | −$1.89 | −$1.75 |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | −$0.291 | −$0.081 | −$12.301 | — |
| Growth vs a year ago | — | — | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterDec 2026 | Next quarterMar 2027 | This yearYear to Dec 2026 | Next yearYear to Dec 2027 |
|---|---|---|---|---|
| Average estimate | $86667.00 | $100000.00 | $233333.00 | $266667.00 |
| Lowest estimate | $56078.00 | $83783.00 | $196905.00 | $195124.00 |
| Highest estimate | $101961.00 | $108108.00 | $295358.00 | $390249.00 |
| Number of analysts | 3 | 3 | 3 | 3 |
| A year ago | $75000.00 | $39000.00 | $241000.00 | — |
| Growth vs a year ago | +15.6% | +156.4% | −3.2% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Envoy Medical, Inc.. Envoy Medical, Inc. has reported as a listed company since 2021. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | Mkt cap |
|---|---|---|---|---|---|
| CCMConcord Medical Services Holdings Limited | Healthcare | Medical - Care Facilities | $522,454 | ||
| CDTCDT Equity Inc. | Healthcare | Biotechnology | $159,886 | ||
| HEPAHepion Pharmaceuticals, Inc. | Healthcare | Biotechnology | $848,283 | ||
| NIVFNewGenIvf Group Limited | Healthcare | Medical - Care Facilities | $209,314 | ||
| PETVPetVivo Holdings, Inc. | Healthcare | Medical - Devices | $20.1M | ||
| PTPIPetros Pharmaceuticals, Inc. | Healthcare | Drug Manufacturers - Specialty & Generic | $155,801 | ||
| SYRASyra Health Corp. Class A Common Stock | Healthcare | Medical - Care Facilities | $907,134 | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| RYLPFKoninklijke Philips N.V. | Healthcare | OTC | $29.9B | ||
| SEMHFSiemens Healthineers AG | Healthcare | OTC | $56.3B | ||
| SENSSenseonics Holdings, Inc. | Healthcare | NASDAQ | $533.6M | ||
| SGHTSight Sciences, Inc. | Healthcare | NASDAQ | $598.6M | ||
| SHOMSouthern Home Medical, Inc. | Healthcare | OTC | $398,670 | ||
| SIBNSI-BONE, Inc. | Healthcare | NASDAQ | $1.1B | ||
| SINTSintx Technologies, Inc. | Healthcare | NASDAQ | $9.1M | ||
| SMMNYSiemens Healthineers AG | Healthcare | PNK | $110.6B | ||
| SNNSmith & Nephew plc | Healthcare | NYSE | $12.7B | ||
| SNNUFSmith & Nephew plc | Healthcare | OTC | $15.3B | ||
| SNWVSANUWAVE Health, Inc. | Healthcare | NASDAQ | $14.7M | ||
| SNZZFSenzime AB (publ) | Healthcare | OTC | $84.1M | ||
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Envoy Medical, Inc., and how their positions are changing. At a $540,800 market value, institutional positions materially move Envoy Medical, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Envoy Medical, Inc. executives and directors. Shares of Envoy Medical, Inc. have traded between $0.04 and $0.04 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Envoy Medical, Inc.. Coverage tracks Envoy Medical, Inc. within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Envoy Medical, Inc.